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Background and aims. Inflammation is a contributor to the dysfunction 
of insulin-secreting pancreatic beta-cells in Diabetes Mellitus (DM). 
Exosomes (EXOs) have emerged as important mediators in cell 
communication, which carry proteins and RNA species (miRNA, mRNA, 
tRNAs etc). EXOs have been found under normal physiologic and disease 
states. Their content can reflect biological events and disease 
progression. In the present study, we are defining the miRNA profiles 
of beta cells and EXOs, with and without exposure to inflammatory 
cytokines. By comparing our data to literary references, it will be 
possible to identify miRNAs that may reflect beta cell damage and/or 
death. 
 
 
Methods. To determine the effect of miRNA expression released by 
beta-cells under inflammatory and non-inflammatory conditions, 
pancreatic beta cell line MIN6 was cultured in presence or absence of 
a mixture of cytokines (IL-1β, TNF-α and IFN-γ) for 48h. Glucose 
Stimulated Insulin Secretion assay was performed in the cells after 
48h. MIN6-derived Exosomes were isolated from the different 
conditions, quantified, and characterized by Nanoparticle tracking 
analysis (Nanosight, Malvern), flow cytometry, and western blot. Total 
RNA was isolated and an 800 miRNA microarray profiling was carried out 
in cells and exosomes to identify miRNAs with altered abundance in 
response to cytokine exposure. The obtained data was analyzed by 
nSolver software (Nanostring). A two- tailed T-Test was conducted in 
order to determine the significance in the up or down regulation of 
various miRNAs. 
 
 
Results.  We found that inflammation did not affect the majority of 
the miRNAs in MIN6 cells and exosomes. However, mmu-let-7, 
mmu-miR-101b, mmu-miR-125a, mmu-miR-127, mmu-miR-185, mmu-miR-2141, 
mmu-miR-29, mmu-miR-337-3p, mmu-miR-425, mmu-miR-487b, mmu-miR-539, 
mmu-miR-540-3p and mmu-miR-99b were differentially expressed (p-value 
< 0.05) in treated and non-treated cells. Exosomes released by treated 
and non-treated cells, significantly differed in the expression of 
mmu-miR-129-3p, mmu-miR-2134, mmu-miR-2135, mmu-miR-328 and 
mmu-miR-384-3p (p-value < 0.05). 
 
 
Conclusions. Our results suggest that beta-cells under inflammatory 
conditions modify the secretion of microRNAs associated with 
regulation of insulin signaling and secretion, diabetes, and beta 
cells. Taken together, this miRNA expression profiles revealed 
potential targets that could serve as a novel, non-invasive, accurate, 
and time-sensitive biomarker to monitor progression, and may identify 
molecular targets for therapeutic interventions of DM. 
